Answers are grounded in this paper and cite their sources.
Cyril C. Y. Yipa*, Siddharth Sridharbcde*, John H. N. Laua, Andrew K. W. Chenga, Kit-Hang Leungb, Jonathan H. K. Chena , Kwok-Hung Chanb, Vincent C. C. Chenga & Kwok-Yung Yuenabcdef*a Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, Chinab Department of Microbiology, The University of Hong Kong, Hong Kong Special Administrative Region, Chinac State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong Special Administrative Region, Chinad Research Centre of Infection and Immunology, The University of Hong Kong, Hong Kong Special Administrative Region, Chinae Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, Chinaf Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, ChinaCONTACT Kwok-Yung Yuen kyyuen@hkucc.hku.hk Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China* These authors contributed equally to this workABSTRACTObjectives Accurate assays for hepatitis C virus (HCV) quantitation and genotyping are important for the management of HCV infection. In this study, we evaluated the performance of cobas HCV and cobas HCV GT assays (Roche) for HCV quantitation and genotyping on the cobas 4800 System.Methods We compared the performance of the cobas HCV assays with another commercial system (Abbott m2000) using a panel of well-characterized patient samples and proficiency testing samples.Results The limit-of-detection of the cobas HCV assay in our center was higher (15 IU/mL) than the manufacturer claim (9.2 IU/mL). The assay showed high analytical specificity, accuracy, precision, and linearity. Performance was congruent with the RealTime HCV assay (Abbott). For genotyping, the cobas HCV GT assay only showed moderate agreement with the RealTime HCV Genotype II assay (kappa = 0.550). The cobas assay outperformed the RealTime assay for typing HCV genotypes 1b and 6 (p = 0.033).Conclusion Our results confirm that the cobas 4800 System is a reliable platform for HCV quantitation and genotyping. The cobas HCV GT assay is a good choice for genotype 1b/6 endemic areas in east Asia, clearly outperforming the RealTime HCV Genotype II assay.
No takes yet. Share an insight, caveat, or question.
Yip et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: